- Home
- CTRE vs KYMR Comparison
CTRE vs KYMR Comparison
Compare CTRE & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRE | KYMR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CTRE | KYMR |
|---|---|---|
| Price | $36.05 | $72.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 23 |
| Target Price | $40.00 | ★ $105.35 |
| AVG Volume (30 Days) | ★ 1.8M | 1.5M |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ 90.43 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $428,478,000.00 | $43,735,000.00 |
| Revenue This Year | $23.27 | $18.71 |
| Revenue Next Year | $27.02 | N/A |
| P/E Ratio | $27.00 | ★ N/A |
| Revenue Growth | ★ 59.24 | N/A |
| 52 Week Low | $24.79 | $19.45 |
| 52 Week High | $38.32 | $103.00 |
Technical Indicators
Market Signals| Indicator | CTRE | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 43.46 |
| Support Level | $36.57 | $77.28 |
| Resistance Level | $37.25 | $85.41 |
| Average True Range (ATR) | 0.64 | 3.34 |
| MACD | -0.09 | -1.99 |
| Stochastic Oscillator | 54.38 | 13.99 |
Price Performance
Historical ComparisonAbout CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.